# MAYZENT
> **NDA209884** · New Drug Application · Sponsor: NOVARTIS · Approved 2019-03-26
## Drug
- **FDA Application Number:** NDA209884
- **Application type:** New Drug Application
- **Brand name:** MAYZENT
- **Generic name:** SIPONIMOD
- **Active ingredients:** SIPONIMOD
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** NOVARTIS
- **Manufacturer:** Novartis Pharmaceuticals Corporation
- **First approval:** 2019-03-26
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209884)
---
*AI Analytics · CC0 1.0*